Baxter International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.03.14	Baxter Plans To Split Into Two Companies - Quick Facts (RTTNews)
23.01.14	Baxter International Q4 Results Top View; Sees FY14 EPS Above Estimates (RTTNews)
23.01.14	Baxter Q4 Profit Down, But Adj EPS. Tops Estimate; Sees Q1 Adj. EPS Below View (RTTNews)
19.12.13	Baxter's FEIBA Gets Addl. Indication For Routine Prophylaxis In Hemophilia A&B (RTTNews)
11.12.13	AVNR's PRIME Flops, BG Medicine Tastes Sweet, CYTR Awaits Data, ENTA Shines (RTTNews)
10.12.13	Baxter Submits BLA For Approval Of OBI-1 For Patients With Acquired Hemophilia A (RTTNews)
09.12.13	Baxter Files For Pediatric Indication Of Rixubis Treatment For Hemophilia B (RTTNews)
02.12.13	Baxter Submits Amended Biologics License Application For HyQvia To FDA (RTTNews)
15.11.13	Baxter, Cell Therapeutics Collaborate To Develop, Commercialize Pacritinib (RTTNews)
13.11.13	Baxter Int'l Closes Enrollment In Phase III Clinical Trial Of BAX 855 (RTTNews)
31.10.13	Baxter Submits Application To Market RIXUBIS In Europe (RTTNews)
17.10.13	Baxter Profit Meets View, But Revenues Miss (RTTNews)
17.10.13	Baxter Q3 Profit Declines On Gambro Acquisition Costs, Adj. EPS Matches View (RTTNews)
11.10.13	Morning Research: Baxter Intl. Inc., CareFusion Corp., Mindray Medical Intl. Ltd, and Unilife Corp. (PR Newswire)
30.09.13	Product Recalls, Relief Efforts, New Term Loans, Mixed Legal Verdict, and Product Launches - Research Report on Baxter, Covidien, Cooper, BD, and Teleflex (PR Newswire)
27.09.13	Updates on Pipeline Developments, Facility Expansions, and Conference Calls - Research Report on Merck, UnitedHealth, Amgen, Baxter, and Charles River (PR Newswire)
19.09.13	Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter (PR Newswire)
11.09.13	Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance (PR Newswire)
06.09.13	Baxter Closes Acquisition Of Gambro AB - Quick Facts (RTTNews)
03.09.13	Baxter, Coherus Announce Collaboration To Develop Biosimilars (RTTNews)
03.09.13	Investors Conferences and FDA-Approved Products - Research Report on Baxter International, CR Bard, BD, Cooper, and Thoratec (PR Newswire)
07.08.13	Collaborations, Global Platforms, and Strong Sales Drive Revenue Growth - Research Report on Baxter, Mylan, ImmunoGen, Emeritus, and Synta (PR Newswire)
05.08.13	Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical (PR Newswire)
01.08.13	FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard (PR Newswire)
23.07.13	Increased Demand, Fast Track Designations, and Strong Sales Boost Revenue Growth - Research Report on Alexion, Baxter International, Align Technology, Transition, and OPKO (PR Newswire)
18.07.13	Baxter International Q2 Profit Beats Estimates - Quick Facts (RTTNews)
18.07.13	Earnings Watch For July 18 (UNH, VZ, GOOG, MSFT, PM, RMBS) (RTTNews)
02.03.10	FDA Classifies Baxter’s January HomeChoice Peritoneal Dialysis Cycler Field Corrective Action as a Class I Recall (Businesswire)
16.03.09	Data Presented at AAAAI Reinforce Baxter’s Commitment to Making GAMMAGARD LIQUID Therapy More Convenient (Businesswire)
10.03.09	Baxter and Its Foundation Contribute Nearly $44 Million in 2008 to Address Critical Needs Locally and Globally (Businesswire)
22.01.09	Baxter Achieves Record Sales, Earnings and Cash Flow for Full-Year 2008 (Businesswire)
06.05.08	Baxter's Board of Directors Declares Quarterly Dividend (PR Newswire)
17.04.08	Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced (PR Newswire)
04.02.08	Baxter's Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing (PR Newswire)
05.11.07	Baxter Kidney Patient Education Program Celebrates Tenth Anniversary (PR Newswire)
20.04.07	Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference (PR Newswire)
31.03.07	Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency (PR Newswire)
14.12.06	Baxter Receives Conditional Approval for U.S. COLLEAGUE Infusion Pump Corrective Action Plan and Submits Updated 510(k) Pre-Market Notification (PR Newswire)
14.09.06	Baxter Names Carlos Alonso President of Latin American Region (PR Newswire)
06.06.06	The Baxter International Foundation Awards Grants in Five Countries to Improve Access to Healthcare (PR Newswire)
23.05.06	Baxter Announces Winners of 'Picture Your Tomorrow, Today' Global Photo Contest (PR Newswire)
15.02.06	Baxter's Board Authorizes $1.5 Billion Share Repurchase Program (PR Newswire)
25.01.06	Baxter Mourns Passing of William B. Graham, Pioneer and Long-Time Leader in Healthcare (PR Newswire)
11.11.05	Baxter Inducts Blood Donors From 13 Blood Centers Across the Country Into Donation Hall of Fame (PR Newswire)
27.10.05	National Hemophilia Foundation Grants 2005 Awards Under Baxter-Sponsored NHF Clinical Fellowship Program (PR Newswire)
23.09.05	Baxter Prevails in Sevoflurane Patent Dispute (PR Newswire)
08.08.05	Halozyme Therapeutics and Baxter Healthcare Corporation Expand Relationship to Include European Union (PR Newswire)
21.07.05	Baxter Reports Earnings Per Share of $0.51 and 8 Percent Increase in Sales in Second Quarter (PR Newswire)
26.05.05	The Baxter International Foundation Awards Grants in Six Countries to Improve Access to Healthcare (PR Newswire)
02.05.05	FDA Approves Baxter's GAMMAGARD Liquid 10% for Patients With Primary I (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

23.04.25		Fresenius Medical Care (FMC) St-Analyse: Fresenius Medical Care (FMC) St-Aktie von UBS AG mit Neutral bewertet
23.04.25		JP Morgan Chase & Co.: Fresenius SE-Aktie erhält Overweight
23.04.25		Fresenius Medical Care (FMC) St-Analyse: Goldman Sachs Group Inc. vergibt Buy an Fresenius Medical Care (FMC) St-Aktie
22.04.25		Aktien-Tipp Fresenius Medical Care (FMC) St-Aktie: Deutsche Bank AG bewertet Anteilsschein in neuer Analyse
22.04.25		Buy von Deutsche Bank AG für Fresenius SE-Aktie
22.04.25		DAX 40-Titel Fresenius SE-Aktie: So viel hätten Anleger an einem Fresenius SE-Investment von vor einem Jahr verdient
22.04.25		Erste Schätzungen: Fresenius SE legt Quartalsergebnis vor
21.04.25		DAX 40-Wert Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 3 Jahren bedeutet

23.04.25

Fresenius Medical Care (FMC) St-Analyse: Fresenius Medical Care (FMC) St-Aktie von UBS AG mit Neutral bewertet

23.04.25

JP Morgan Chase & Co.: Fresenius SE-Aktie erhält Overweight

23.04.25

Fresenius Medical Care (FMC) St-Analyse: Goldman Sachs Group Inc. vergibt Buy an Fresenius Medical Care (FMC) St-Aktie

22.04.25

Aktien-Tipp Fresenius Medical Care (FMC) St-Aktie: Deutsche Bank AG bewertet Anteilsschein in neuer Analyse

22.04.25

Buy von Deutsche Bank AG für Fresenius SE-Aktie

22.04.25

DAX 40-Titel Fresenius SE-Aktie: So viel hätten Anleger an einem Fresenius SE-Investment von vor einem Jahr verdient

22.04.25

Erste Schätzungen: Fresenius SE legt Quartalsergebnis vor

21.04.25

DAX 40-Wert Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 3 Jahren bedeutet

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	245.40	1.53 %	K V
Sika	199.70	0.96 %	K V
Givaudan	3’807.00	0.85 %	K V
Swiss Life Hldg	798.40	0.81 %	K V
Kuehne+Nagel Int	188.95	0.77 %	K V
Alcon	77.54	-0.51 %	K V
Logitech Intl	61.52	-0.58 %	K V
Nestle	86.79	-0.70 %	K V
Part Grp Hldg	1’061.00	-0.70 %	K V
CieFinRichemont	142.60	-0.83 %	K V

Baxter International Aktie VALOR 911702 / ISIN US0718131099

Nachrichten zu Baxter International Inc.

Aktien Top/Flop

Baxter International Peer Group Nachrichten

Meistgelesene Nachrichten